CMS’ Literal Read Of Non-Opioid Pain Incentive Excludes Recently Approved Product

 
• By Laura Helbling
  
Vertex’s Journavx will not receive separate CMS payments under the NO PAIN Act. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from United States